{"changes":[],"country":"US","description":"Secretome Therapeutics develops regenerative medicines from neonatal cardiac progenitor cells, with lead programs STM-01 and STM-2 for heart failure including HFpEF. It targets patients with serious cardiac disease lacking good options. Its neonatal cells give near-zero variability and reportedly triple the potency of adult cells.","domain":"secretometx.com","employees":null,"founded":null,"fundingTotalQuarantined":false,"githubOrg":null,"githubStars":null,"industry":"healthcare","investors":[],"lat":null,"lng":null,"location":"US","name":"Secretome Therapeutics","rounds":[{"amountQuarantined":false,"amountUsd":30000000,"currency":"USD","date":"2026-05-27","investors":[],"leadInvestor":null,"source":{"fact":"round","publisher":"crunchbase","retrievedAt":"2026-06-16","status":"attributed","url":null},"status":"attributed","type":"series-a","url":null}],"slug":"secretometx-com","sources":[{"fact":"round","publisher":"crunchbase","retrievedAt":"2026-06-16","status":"attributed","url":null},{"fact":"existence","publisher":"secretometx.com","retrievedAt":"2026-06-16","status":"self-reported","url":"https://secretometx.com"},{"fact":"description","publisher":"secretometx.com","retrievedAt":"2026-06-16","status":"self-reported","url":"https://secretometx.com"}],"stage":"series-a","techStack":["bootstrap 5.3.3","cdnjs","cloudflare","express","hsts","http/3","jquery 3.7.1","jquery cdn","jsdelivr","nginx","node.js","slick 1.9.0"],"totalRaisedUsd":30000000,"updatedAt":"2026-06-16"}